Track: Breast Cancer
Sub-Track:
Breast cancer tissue is frequently analysed for the biomarkers ER, PR, and HER2 to aid with treatment decisions. A biomarker is any gene, protein, or other substance that may be detected in the blood, tissues, or other bodily fluids. Research on the possibility that testing for additional biomarkers, such HER3, could possibly be beneficial is being conducted in certain studies, but it is still in its early stages. When cancer cells perish, DNA known as circulating tumour DNA (ctDNA) is released into the bloodstream. Identifying and evaluating ctDNA in blood for biomarkers is a rapidly emerging field of inquiry.
• Radiation Therapy
• Biopsy
Scientific Highlights
- Field of Oncology
- Cancer Cell Biology & Genetics
- Cancer Imaging Techniques
- Diagnosis & Treatment of Cancer
- Advances In Cancer Research And Treatment
- Cancer- Types and Causes
- Breast Cancer
- Blood Cancer
- Head/ Neck Cancer
- Neuro-Oncology
- Skin Cancer
- Pelvic Cancer
- Cancer Immunology
- Oncology Nursing and Care
- Cancer Stem Cells
- Women Health Issues and Policies
- Cancer Drugs Market
- Cancer Therapy and Research
- Survivorship After Treatment
- Personalized Medicine
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801 USA
Mail us at
Program Enquiry
oncology@scientexconferences.com
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
oncology@scientexconferences.com
Our Social Presence
Call us at
USA :(+1) 323 677 0554